Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash-to-Debt 0.08
NAS:LHCG's Cash-to-Debt is ranked lower than
77% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 0.37 vs. NAS:LHCG: 0.08 )
Ranked among companies with meaningful Cash-to-Debt only.
NAS:LHCG' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.29 Max: No Debt
Current: 0.08
Equity-to-Asset 0.62
NAS:LHCG's Equity-to-Asset is ranked higher than
67% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 0.50 vs. NAS:LHCG: 0.62 )
Ranked among companies with meaningful Equity-to-Asset only.
NAS:LHCG' s Equity-to-Asset Range Over the Past 10 Years
Min: 0.34  Med: 0.72 Max: 0.82
Current: 0.62
0.34
0.82
Debt-to-Equity 0.20
NAS:LHCG's Debt-to-Equity is ranked higher than
80% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 0.63 vs. NAS:LHCG: 0.20 )
Ranked among companies with meaningful Debt-to-Equity only.
NAS:LHCG' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.02  Med: 0.08 Max: 1.12
Current: 0.2
0.02
1.12
Debt-to-EBITDA 0.92
NAS:LHCG's Debt-to-EBITDA is ranked higher than
80% of the 197 Companies
in the Global Medical Care industry.

( Industry Median: 2.82 vs. NAS:LHCG: 0.92 )
Ranked among companies with meaningful Debt-to-EBITDA only.
NAS:LHCG' s Debt-to-EBITDA Range Over the Past 10 Years
Min: 0.08  Med: 0.42 Max: 11.93
Current: 0.92
0.08
11.93
Interest Coverage 24.75
NAS:LHCG's Interest Coverage is ranked higher than
68% of the 224 Companies
in the Global Medical Care industry.

( Industry Median: 7.55 vs. NAS:LHCG: 24.75 )
Ranked among companies with meaningful Interest Coverage only.
NAS:LHCG' s Interest Coverage Range Over the Past 10 Years
Min: 18.3  Med: 35.04 Max: 713.45
Current: 24.75
18.3
713.45
Piotroski F-Score: 4
Altman Z-Score: 5.56
Beneish M-Score: -2.58
WACC vs ROIC
5.83%
10.77%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 6/10

vs
industry
vs
history
Operating Margin % 8.15
NAS:LHCG's Operating Margin % is ranked higher than
54% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 7.34 vs. NAS:LHCG: 8.15 )
Ranked among companies with meaningful Operating Margin % only.
NAS:LHCG' s Operating Margin % Range Over the Past 10 Years
Min: -1.01  Med: 8.33 Max: 15.99
Current: 8.15
-1.01
15.99
Net Margin % 4.13
NAS:LHCG's Net Margin % is ranked higher than
50% of the 267 Companies
in the Global Medical Care industry.

( Industry Median: 4.16 vs. NAS:LHCG: 4.13 )
Ranked among companies with meaningful Net Margin % only.
NAS:LHCG' s Net Margin % Range Over the Past 10 Years
Min: -2.09  Med: 4.15 Max: 10.95
Current: 4.13
-2.09
10.95
ROE % 10.19
NAS:LHCG's ROE % is ranked higher than
55% of the 250 Companies
in the Global Medical Care industry.

( Industry Median: 9.23 vs. NAS:LHCG: 10.19 )
Ranked among companies with meaningful ROE % only.
NAS:LHCG' s ROE % Range Over the Past 10 Years
Min: -4.93  Med: 10.04 Max: 26.16
Current: 10.19
-4.93
26.16
ROA % 6.36
NAS:LHCG's ROA % is ranked higher than
67% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.45 vs. NAS:LHCG: 6.36 )
Ranked among companies with meaningful ROA % only.
NAS:LHCG' s ROA % Range Over the Past 10 Years
Min: -3.51  Med: 6.61 Max: 20.02
Current: 6.36
-3.51
20.02
ROC (Joel Greenblatt) % 76.60
NAS:LHCG's ROC (Joel Greenblatt) % is ranked higher than
84% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 14.51 vs. NAS:LHCG: 76.60 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
NAS:LHCG' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: -4.82  Med: 63.16 Max: 147.21
Current: 76.6
-4.82
147.21
3-Year Revenue Growth Rate 10.40
NAS:LHCG's 3-Year Revenue Growth Rate is ranked higher than
63% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 7.70 vs. NAS:LHCG: 10.40 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
NAS:LHCG' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: 3.5  Med: 20.5 Max: 60.7
Current: 10.4
3.5
60.7
3-Year EBITDA Growth Rate 13.40
NAS:LHCG's 3-Year EBITDA Growth Rate is ranked higher than
67% of the 186 Companies
in the Global Medical Care industry.

( Industry Median: 7.10 vs. NAS:LHCG: 13.40 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
NAS:LHCG' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -64.8  Med: 28.7 Max: 171.3
Current: 13.4
-64.8
171.3
3-Year EPS without NRI Growth Rate 16.80
NAS:LHCG's 3-Year EPS without NRI Growth Rate is ranked higher than
67% of the 163 Companies
in the Global Medical Care industry.

( Industry Median: 7.00 vs. NAS:LHCG: 16.80 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
NAS:LHCG' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: -21.4  Med: 24.8 Max: 112.8
Current: 16.8
-21.4
112.8
GuruFocus has detected 4 Warning Signs with LHC Group Inc NAS:LHCG.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» NAS:LHCG's 30-Y Financials

Financials (Next Earnings Date: 2017-11-03)


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q3 2016

LHCG Guru Trades in Q3 2016

Paul Tudor Jones 6,900 sh (New)
Steven Cohen 44,900 sh (+41.64%)
Jim Simons 172,000 sh (+40.64%)
Joel Greenblatt 15,563 sh (-60.03%)
» More
Q4 2016

LHCG Guru Trades in Q4 2016

Steven Cohen 112,000 sh (+149.44%)
Paul Tudor Jones 8,390 sh (+21.59%)
Joel Greenblatt 12,915 sh (-17.01%)
Jim Simons 91,600 sh (-46.74%)
» More
Q1 2017

LHCG Guru Trades in Q1 2017

Steven Cohen 439,399 sh (+292.32%)
Jim Simons 141,500 sh (+54.48%)
Joel Greenblatt Sold Out
Paul Tudor Jones 7,456 sh (-11.13%)
» More
Q2 2017

LHCG Guru Trades in Q2 2017

Joel Greenblatt 13,227 sh (New)
Chuck Royce 15,000 sh (New)
Paul Tudor Jones Sold Out
Jim Simons 134,400 sh (-5.02%)
Steven Cohen 363,400 sh (-17.30%)
» More
» Details

Insider Trades

Latest Guru Trades with LHCG

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Joel Greenblatt 2017-06-30 New Buy0.01%$51.76 - $68.35 $ 67.6614%13,227
Joel Greenblatt 2017-03-31 Sold Out 0.01%$44.64 - $54.1 $ 67.6639%0
Joel Greenblatt 2016-12-31 Reduce -17.01%$32.48 - $45.7 $ 67.6666%12,915
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 621610    SIC: 8082
Compare:LSE:SPI, TSE:7716, ASX:PRY, BOM:532843, BKK:SVH, BKK:BCH-F, SAU:4007, BKK:VIBHA, BKK:RAM, XKLS:5878, SGX:BSL, SAU:4009, ISX:SILO, NYSE:THC, NSE:NH, HKSE:01515, NAS:TVTY, XSWX:AEVS, NYSE:CYH, BKK:CHG-F » details
Traded in other countries:LH6.Germany,
Headquarter Location:USA
LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

LHC Group Inc provides post-acute health care services to patients through its home nursing agencies, community-based services agencies, hospice agencies and long-term acute care hospitals.

Top Ranked Articles about LHC Group Inc

LHC Group Announces Third Quarter 2017 Earnings Release and Conference Call Dates
LHC Group to Present at Baird 2017 Global Healthcare Conference
LHC Group Announces Second Quarter 2017 Earnings Release and Conference Call Dates
Insiders Roundup: Medley Capital, LHC Group Largest insider buys and sales of the week
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “June 2017” and All Insider Sales to “$5,000,000+.” Read more...
Insiders Roundup: SeaWorld, Kinder Morgan, Salesforce Largest insider trades for the week of May 29
The GuruFocus All-in-One Screener can be used to find insider trades from the past week. Under the Insiders tab, change the settings for All Insider Buying to “$200,000+,” the duration to “June 2017” and “May 2017” and All Insider Sales to “$5,000,000+.” Read more...
LHC Group to Present at Jefferies 2017 Global Healthcare Conference
LHC Group again tops CMS Five-Star Quality Rating System results
LHC Group to Present at Bank of America Merrill Lynch 2017 Health Care Conference
LHC Group and Baptist Announce Joint Venture to Provide Home Health and Hospice Care
LHC Group Announces First Quarter 2017 Earnings Release and Conference Call Dates

Ratios

vs
industry
vs
history
PE Ratio 30.07
LHCG's PE Ratio is ranked lower than
60% of the 200 Companies
in the Global Medical Care industry.

( Industry Median: 26.57 vs. LHCG: 30.07 )
Ranked among companies with meaningful PE Ratio only.
LHCG' s PE Ratio Range Over the Past 10 Years
Min: 7.62  Med: 18.45 Max: 32.35
Current: 30.07
7.62
32.35
Forward PE Ratio 26.04
LHCG's Forward PE Ratio is ranked lower than
84% of the 58 Companies
in the Global Medical Care industry.

( Industry Median: 19.88 vs. LHCG: 26.04 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 30.07
LHCG's PE Ratio without NRI is ranked lower than
61% of the 196 Companies
in the Global Medical Care industry.

( Industry Median: 26.50 vs. LHCG: 30.07 )
Ranked among companies with meaningful PE Ratio without NRI only.
LHCG' s PE Ratio without NRI Range Over the Past 10 Years
Min: 7.62  Med: 18.26 Max: 32.35
Current: 30.07
7.62
32.35
Price-to-Owner-Earnings 29.18
LHCG's Price-to-Owner-Earnings is ranked lower than
54% of the 106 Companies
in the Global Medical Care industry.

( Industry Median: 26.22 vs. LHCG: 29.18 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
LHCG' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.64  Med: 20.48 Max: 74.26
Current: 29.18
6.64
74.26
PB Ratio 2.88
LHCG's PB Ratio is ranked lower than
61% of the 251 Companies
in the Global Medical Care industry.

( Industry Median: 2.62 vs. LHCG: 2.88 )
Ranked among companies with meaningful PB Ratio only.
LHCG' s PB Ratio Range Over the Past 10 Years
Min: 0.88  Med: 1.92 Max: 4.51
Current: 2.88
0.88
4.51
PS Ratio 1.24
LHCG's PS Ratio is ranked higher than
60% of the 259 Companies
in the Global Medical Care industry.

( Industry Median: 1.70 vs. LHCG: 1.24 )
Ranked among companies with meaningful PS Ratio only.
LHCG' s PS Ratio Range Over the Past 10 Years
Min: 0.35  Med: 0.84 Max: 2.35
Current: 1.24
0.35
2.35
Price-to-Free-Cash-Flow 16.77
LHCG's Price-to-Free-Cash-Flow is ranked higher than
65% of the 124 Companies
in the Global Medical Care industry.

( Industry Median: 22.48 vs. LHCG: 16.77 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
LHCG' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 3.89  Med: 12.76 Max: 76.05
Current: 16.77
3.89
76.05
Price-to-Operating-Cash-Flow 15.16
LHCG's Price-to-Operating-Cash-Flow is ranked lower than
54% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 14.62 vs. LHCG: 15.16 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
LHCG' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 3.67  Med: 10.08 Max: 149.26
Current: 15.16
3.67
149.26
EV-to-EBIT 16.83
LHCG's EV-to-EBIT is ranked higher than
59% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 20.85 vs. LHCG: 16.83 )
Ranked among companies with meaningful EV-to-EBIT only.
LHCG' s EV-to-EBIT Range Over the Past 10 Years
Min: -80.8  Med: 9.4 Max: 94.9
Current: 16.83
-80.8
94.9
EV-to-EBITDA 14.53
LHCG's EV-to-EBITDA is ranked higher than
50% of the 227 Companies
in the Global Medical Care industry.

( Industry Median: 15.17 vs. LHCG: 14.53 )
Ranked among companies with meaningful EV-to-EBITDA only.
LHCG' s EV-to-EBITDA Range Over the Past 10 Years
Min: -74.8  Med: 8.8 Max: 137.5
Current: 14.53
-74.8
137.5
EV-to-Revenue 1.38
LHCG's EV-to-Revenue is ranked higher than
68% of the 265 Companies
in the Global Medical Care industry.

( Industry Median: 2.18 vs. LHCG: 1.38 )
Ranked among companies with meaningful EV-to-Revenue only.
LHCG' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.4  Med: 0.9 Max: 2.3
Current: 1.38
0.4
2.3
PEG Ratio 0.46
LHCG's PEG Ratio is ranked higher than
94% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 3.00 vs. LHCG: 0.46 )
Ranked among companies with meaningful PEG Ratio only.
LHCG' s PEG Ratio Range Over the Past 10 Years
Min: 0.25  Med: 0.36 Max: 0.6
Current: 0.46
0.25
0.6
Shiller PE Ratio 39.67
LHCG's Shiller PE Ratio is ranked lower than
62% of the 55 Companies
in the Global Medical Care industry.

( Industry Median: 27.79 vs. LHCG: 39.67 )
Ranked among companies with meaningful Shiller PE Ratio only.
LHCG' s Shiller PE Ratio Range Over the Past 10 Years
Min: 14  Med: 23.9 Max: 41.1
Current: 39.67
14
41.1
Current Ratio 1.74
LHCG's Current Ratio is ranked higher than
62% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.41 vs. LHCG: 1.74 )
Ranked among companies with meaningful Current Ratio only.
LHCG' s Current Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.17 Max: 4.45
Current: 1.74
1.65
4.45
Quick Ratio 1.74
LHCG's Quick Ratio is ranked higher than
66% of the 253 Companies
in the Global Medical Care industry.

( Industry Median: 1.31 vs. LHCG: 1.74 )
Ranked among companies with meaningful Quick Ratio only.
LHCG' s Quick Ratio Range Over the Past 10 Years
Min: 1.65  Med: 2.17 Max: 4.45
Current: 1.74
1.65
4.45
Days Sales Outstanding 49.12
LHCG's Days Sales Outstanding is ranked lower than
59% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 41.26 vs. LHCG: 49.12 )
Ranked among companies with meaningful Days Sales Outstanding only.
LHCG' s Days Sales Outstanding Range Over the Past 10 Years
Min: 46.2  Med: 49.57 Max: 85.77
Current: 49.12
46.2
85.77

Buy Back

vs
industry
vs
history
3-Year Average Share Buyback Ratio -0.90
LHCG's 3-Year Average Share Buyback Ratio is ranked higher than
66% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. LHCG: -0.90 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
LHCG' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -13.5  Med: -0.7 Max: 2
Current: -0.9
-13.5
2

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.58
LHCG's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
59% of the 103 Companies
in the Global Medical Care industry.

( Industry Median: 1.98 vs. LHCG: 1.58 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
LHCG' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 0.34  Med: 0.61 Max: 1.59
Current: 1.58
0.34
1.59
Price-to-Median-PS-Value 1.48
LHCG's Price-to-Median-PS-Value is ranked lower than
79% of the 232 Companies
in the Global Medical Care industry.

( Industry Median: 1.03 vs. LHCG: 1.48 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
LHCG' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.44  Med: 1.05 Max: 2.82
Current: 1.48
0.44
2.82
Earnings Yield (Greenblatt) % 5.94
LHCG's Earnings Yield (Greenblatt) % is ranked higher than
68% of the 269 Companies
in the Global Medical Care industry.

( Industry Median: 3.79 vs. LHCG: 5.94 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
LHCG' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: -3.8  Med: 9.7 Max: 25.9
Current: 5.94
-3.8
25.9
Forward Rate of Return (Yacktman) % -19.30
LHCG's Forward Rate of Return (Yacktman) % is ranked lower than
91% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 8.93 vs. LHCG: -19.30 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
LHCG' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: -10842.8  Med: 12.95 Max: 28946.6
Current: -19.3
-10842.8
28946.6

More Statistics

Revenue (TTM) (Mil) $973.07
EPS (TTM) $ 2.25
Beta0.63
Short Percentage of Float7.60%
52-Week Range $32.04 - 73.85
Shares Outstanding (Mil)18.28

Analyst Estimate

Dec17 Dec18
Revenue (Mil $) 1,050 1,163
EPS ($) 2.30 2.59
EPS without NRI ($) 2.30 2.59
EPS Growth Rate
(Future 3Y To 5Y Estimate)
15.00%
Dividends per Share ($)

Piotroski F-Score Details

Piotroski F-Score: 44
Positive ROAY
Positive CFROAY
Higher ROA yoyN
CFROA > ROAY
Lower Leverage yoyY
Higher Current Ratio yoyN
Less Shares Outstanding yoyN
Higher Gross Margin yoyN
Higher Asset Turnover yoyN

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}